Korro Bio
KRRO· Manufacturing· Fiscal year ends in December
CEO pay in FY2025Stock -79.0% in FY2025
Ram Aiyar is the CEO of Korro Bio and was paid $3.1M in FY2025 (Dec), up 232%.
Pay$100 in the stock at the end of FY21 → $3
Executives5
See all- 1Ram AiyarChief Executive Officer, President and Interim Chief Financial OfficerFY2025
- 2Kemi OlugemoFormer Chief Medical OfficerFY2025
- 3Vineet AgarwalFormer Chief Financial OfficerFY2025
- 4Jeffrey CerioSenior Vice President, General Counsel and Corporate SecretaryFY2025
- 5Loïc VincentChief Scientific OfficerFY2025
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allKorro Bio paid its 5 named executives $10.3M in total in FY2025 (Dec). CEO Ram Aiyar was paid $3.1M of that.
| Name | |||
|---|---|---|---|
| Ram AiyarChief Executive Officer, President and Interim Chief Financial Officer | |||
| Kemi OlugemoFormer Chief Medical Officer | Not disclosed | ||
| Vineet AgarwalFormer Chief Financial Officer | |||
| Jeffrey CerioSenior Vice President, General Counsel and Corporate Secretary | Not disclosed | ||
| Loïc VincentChief Scientific Officer | Not disclosed | Not disclosed |
of each named executive, from the Summary Compensation Table of each proxy.
Peers
No disclosed peer group
No proxy on file names a pay peer group for Korro Bio. The peer group comes from the proxy statement, so it shows here when a proxy read has it.
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 16, 2026 | FY2025 |
| Annual report | 10-K | Mar 12, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 29, 2025 | FY2024 |
| Annual report | 10-K | Mar 18, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 29, 2024 | FY2023 |
| Annual report | 10-K | Mar 26, 2024 | FY2023 |
